Emisphere Technologies (OTCMKTS:EMIS) Reaches New 1-Year High - What's Next?

Key Points

• Emisphere Technologies shares reached a new 52-week high of $9.91 during trading, significantly up from the previous closing price of $7.80.
• The stock saw a notable increase of 27.6% in its price, with a trading volume of 10,002 shares.
• Emisphere is a pharmaceutical and drug delivery company known for Eligen B12 Rx and is currently developing a GLP-1 treatment that is in Phase III clinical trials for type 2 diabetes.

Emisphere Technologies Inc. (OTCMKTS:EMIS - )'s share price hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $9.91 and last traded at $9.91, with a volume of 10002 shares traded. The stock had previously closed at $7.80.

Emisphere Technologies Trading Up 27.6%

The firm has a 50-day moving average price of $7.81 and a two-hundred day moving average price of $7.81.

About Emisphere Technologies

Emisphere Technologies, Inc operates as a commercial stage pharmaceutical and drug delivery company in the United States. The company offers oral Eligen B12 Rx, an oral formulation prescription medical food for use by B12 deficient individuals. It is also developing GLP-1, which is in Phase III clinical trial for the treatment of type 2 diabetes and related conditions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.